References

International Society for Heart and Lung Transplantation guidelines for the evaluation and care of cardiac transplant candidates-2024

10.1016/j.healun.2024.05.010 · 2024 · External reference

2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure

10.1093/eurheartj/ehab368 · 2021 · External reference

Review of the global activity of heart transplant

10.1161/circheartfailure.124.012272 · 2025 · External reference

The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients

10.1016/j.healun.2022.10.015 · 2023 · External reference

Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials

10.1016/j.jacc.2014.01.071 · 2014 · External reference

The end of endomyocardial biopsy?: a practical guide for noninvasive heart transplant rejection surveillance

10.1016/j.jchf.2022.11.002 · 2023 · External reference

Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study

10.1111/ajt.15339 · 2019 · External reference

Summary of the International Society for Heart and Lung Transplantation consensus conference on emerging understanding of antibodies and antibody-mediated rejection in heart transplantation

10.1016/j.healun.2025.02.1690 · 2025 · External reference

Cardiac magnetic resonance in heart transplant recipients: histological, clinical and cell-free DNA validation

10.1093/ehjci/jeaf145 · 2025 · External reference

Multiparametric cardiovascular magnetic resonance characteristics and dynamic changes in asymptomatic heart-transplanted patients

10.1007/s00330-022-09358-2 · 2023 · External reference

Multiparametric cardiovascular magnetic resonance surveillance of acute cardiac allograft rejection and characterisation of transplantation-associated myocardial injury: a pilot study

10.1186/s12968-014-0052-6 · 2014 · External reference

Prognostic value of myocardial extracellular volume fraction and T2-mapping in heart transplant patients

10.1016/j.jcmg.2020.01.014 · 2020 · External reference

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection

10.1016/j.healun.2005.03.019 · 2005 · External reference

The 2013 International Society for Heart and Lung Transplantation working formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation

10.1016/j.healun.2013.08.011 · 2013 · External reference

Cardiac structure-function MRI in patients after heart transplantation

10.1002/jmri.26275 · 2019 · External reference

Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations

10.1016/j.jacc.2018.09.072 · 2018 · External reference

Cardiovascular magnetic resonance feature tracking for rejection surveillance after cardiac transplantation

2025 · External reference

Cardiovascular magnetic resonance for rejection surveillance after cardiac transplantation

10.1161/circulationaha.121.057006 · 2022 · External reference

Multiparametric cardiac magnetic resonance imaging can detect acute cardiac allograft rejection after heart transplantation

10.1016/j.jcmg.2019.01.026 · 2019 · External reference

Native T(1) mapping in the diagnosis of cardiac allograft rejection: a prospective histologically validated study

10.1016/j.jcmg.2018.10.027 · 2019 · External reference

T1 mapping by cardiac magnetic resonance and multidimensional speckle-tracking strain by echocardiography for the detection of acute cellular rejection in cardiac allograft recipients

10.1016/j.jcmg.2018.02.022 · 2019 · External reference

Cardiovascular magnetic resonance in heart transplant patients: diagnostic value of quantitative tissue markers: T2 mapping and extracellular volume fraction, for acute rejection diagnosis

10.1186/s12968-018-0480-9 · 2018 · External reference

Incremental value of multiparametric cardiac magnetic resonance imaging for non-invasive identification of significant acute cardiac allograft rejection: a prospective and biopsy-proven study

10.1093/ehjci/jeaf052 · 2025 · External reference

Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection

10.1016/j.healun.2014.12.020 · 2015 · External reference

Diagnostic accuracy of cardiovascular magnetic resonance for cardiac transplant rejection: a Meta-analysis

10.1016/j.jcmg.2021.05.008 · 2021 · External reference

Pathologic correlates of late gadolinium enhancement cardiovascular magnetic resonance in a heart transplant patient

10.1016/j.carpath.2015.02.001 · 2015 · External reference

Diagnostic performance of multisequential cardiac magnetic resonance imaging in acute cardiac allograft rejection

10.1093/eurjhf/hfp174 · 2010 · External reference

Diagnostic performance of late gadolinium enhancement in the assessment of acute cellular rejection after heart transplantation

2016 · External reference

Prognostic impact of late gadolinium enhancement in the risk stratification of heart transplant patients

10.1093/ehjci/jew186 · 2017 · External reference

Contemporary antibody-mediated rejection in heart transplantation: JACC: heart failure position statement

10.1016/j.jchf.2025.102614 · 2025 · External reference

Significance of elevated donor-derived cell-free DNA in heart transplant recipients with negative endomyocardial biopsies: a dawn of a new era

10.1161/circheartfailure.125.012787 · 2025 · External reference

Cardiac allograft vasculopathy: current review and future research directions

2021 · External reference

Evaluation of cardiac allograft vasculopathy by multidetector computed tomography and whole-heart magnetic resonance coronary angiography

10.1253/circj.cj-09-0800 · 2010 · External reference

Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy

10.1186/s12968-021-00803-7 · 2021 · External reference

Myocardial perfusion reserve and strain-encoded CMR for evaluation of cardiac allograft microvasculopathy

10.1016/j.jcmg.2015.10.012 · 2016 · External reference

Quantitative cardiovascular magnetic resonance myocardial perfusion can discriminate significant cardiac allograft vasculopathy: a multi-centre study

10.1093/ehjci/jeaf201 · 2025 · External reference

Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy

10.1016/j.jacc.2013.07.119 · 2014 · External reference

Multimodal cardiac imaging of immune-mediated complications post heart transplantation: a contemporary review

10.1161/jaha.125.044160 · 2026 · External reference

The use of multimodality imaging in heart transplant recipients: a case series

2025 · External reference

Myocardial fibrosis and prognosis in heart transplant recipients

10.1161/circimaging.119.009060 · 2019 · External reference

Multiparametric quantitative structural and functional cardiac MRI in orthotopic heart transplant recipients with cardiac allograft vasculopathy

10.1007/s10554-025-03384-z · 2025 · External reference

Quantification of myocardial interstitial fibrosis and extracellular volume for the detection of cardiac allograft vasculopathy

10.1007/s10554-019-01733-3 · 2020 · External reference

Cardiac magnetic resonance assessment of acute rejection and cardiac allograft vasculopathy in pediatric heart transplant

10.1016/j.healun.2023.12.006 · 2024 · External reference

Cardiac magnetic resonance imaging in heart transplant recipients with biopsy-negative graft dysfunction

10.1002/ehf2.14681 · 2024 · External reference

Cardiac magnetic resonance feature tracking global longitudinal strain and prognosis after heart transplantation

10.1016/j.jcmg.2020.04.004 · 2020 · External reference

Right ventricular function on cardiovascular magnetic resonance imaging and long-term outcomes in stable heart transplant recipients

10.1161/circimaging.123.016415 · 2024 · External reference

Pericardial effusions after cardiac transplantation

10.1016/0735-1097(94)90666-1 · 1994 · External reference

Clinical course and predictors of pericardial effusion following cardiac transplantation

10.1016/j.transproceed.2006.11.014 · 2007 · External reference

Predictors of pericardial effusion after orthotopic heart transplantation

10.1067/mtc.2002.124387 · 2002 · External reference

Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial

10.1161/01.cir.0000136812.90177.94 · 2004 · External reference

Pericardial constriction after cardiac transplantation

10.1016/j.healun.2009.07.015 · 2010 · External reference

Clinical features and prognosis of surgically proven constrictive pericarditis after orthotopic heart transplantation

10.1016/j.healun.2020.12.010 · 2021 · External reference

Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS guidelines

10.1111/j.1365-2141.2010.08160.x · 2010 · External reference

Myocardial T1 and T2 values are associated with patient age in healthy pediatric heart transplant recipients

10.1016/j.jocmr.2026.102687 · 2026 · External reference

Longitudinal assessment of T1 mapping trends disease in pediatric patients with heart transplant

10.1161/jaha.124.035798 · 2024 · External reference

Quantitative cardiac magnetic resonance T2 imaging offers ability to non-invasively predict acute allograft rejection in children

10.1017/s104795112000116x · 2020 · External reference

Cardiac magnetic resonance imaging noninvasively detects rejection in pediatric heart transplant recipients

10.1161/circimaging.121.013456 · 2022 · External reference

Late-gadolinium enhancement is common in older pediatric heart transplant recipients and is associated with lower ejection fraction

10.1186/s12968-023-00971-8 · 2023 · External reference

Native T1 mapping detects both acute clinical rejection and graft dysfunction in pediatric heart transplant patients

10.1186/s12968-022-00875-z · 2022 · External reference

Multiparametric cardiovascular magnetic resonance is associated with outcomes in pediatric heart transplant recipients

10.1016/j.jocmr.2024.101138 · 2025 · External reference

Diffuse myocardial fibrosis among healthy pediatric heart transplant recipients: correlation of histology, cardiovascular magnetic resonance, and clinical phenotype

10.1111/petr.12986 · 2017 · External reference

Feasibility and safety of quantitative adenosine stress perfusion cardiac magnetic resonance imaging in pediatric heart transplant patients with and without coronary allograft vasculopathy

10.1007/s00247-021-04977-1 · 2021 · External reference

Safety and efficacy of Regadenoson for pediatric stress perfusion cardiac MRI with quantification of myocardial blood flow

10.3390/children9091332 · 2022 · External reference

Cyclosporine in transplantation - a history of converging timelines

2011 · External reference

Barriers to cardiovascular magnetic resonance imaging scan performance and reporting by cardiologists: a systematic literature review

2025 · External reference